Pre-order Enquiry
Request Free Sample
Global and United States Sacral Neuromodulation System Market Report & Forecast 2022-2028
SKU ID : QYR-20736895 | Publishing Date : 18-Apr-2022 | No. of pages : 101
Detailed TOC of Global and United States Sacral Neuromodulation System Market Report & Forecast 2022-2028
1 Study Coverage1.1 Sacral Neuromodulation System Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million) Introduction
1.2 Global Sacral Neuromodulation System Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sacral Neuromodulation System Market Size for the Year 2017-2028
1.2.2 Global Sacral Neuromodulation System Market Size for the Year 2017-2028
1.3 Sacral Neuromodulation System Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Sacral Neuromodulation System in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Sacral Neuromodulation System Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Sacral Neuromodulation System Market Dynamics
1.4.1 Sacral Neuromodulation System Industry Trends
1.4.2 Sacral Neuromodulation System Market Drivers
1.4.3 Sacral Neuromodulation System Market Challenges
1.4.4 Sacral Neuromodulation System Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Sacral Neuromodulation System by Type
2.1 Sacral Neuromodulation System Market Segment by Type
2.1.1 Internal Neuromodulation System
2.1.2 External Neuromodulation System
2.2 Global Sacral Neuromodulation System Market Size by Type (2017, 2022 & 2028)
2.3 Global Sacral Neuromodulation System Market Size by Type (2017-2028)
2.4 United States Sacral Neuromodulation System Market Size by Type (2017, 2022 & 2028)
2.5 United States Sacral Neuromodulation System Market Size by Type (2017-2028)
3 Sacral Neuromodulation System by Application
3.1 Sacral Neuromodulation System Market Segment by Application
3.1.1 Spinal Cord Stimulation
3.1.2 Deep Brain Stimulation
3.1.3 Sacral Nerve Stimulation
3.1.4 Vagus Nerve Stimulation
3.2 Global Sacral Neuromodulation System Market Size by Application (2017, 2022 & 2028)
3.3 Global Sacral Neuromodulation System Market Size by Application (2017-2028)
3.4 United States Sacral Neuromodulation System Market Size by Application (2017, 2022 & 2028)
3.5 United States Sacral Neuromodulation System Market Size by Application (2017-2028)
4 Global Sacral Neuromodulation System Competitor Landscape by Company
4.1 Global Sacral Neuromodulation System Market Size by Company
4.1.1 Top Global Sacral Neuromodulation System Companies Ranked by Revenue (2021)
4.1.2 Global Sacral Neuromodulation System Revenue by Player (2017-2022)
4.2 Global Sacral Neuromodulation System Concentration Ratio (CR)
4.2.1 Sacral Neuromodulation System Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Sacral Neuromodulation System in 2021
4.2.3 Global Sacral Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sacral Neuromodulation System Headquarters, Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million) Type
4.3.1 Global Sacral Neuromodulation System Headquarters and Area Served
4.3.2 Global Sacral Neuromodulation System Companies Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Sacral Neuromodulation System Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Sacral Neuromodulation System Market Size by Company
4.5.1 Top Sacral Neuromodulation System Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sacral Neuromodulation System Revenue by Players (2020, 2021 & 2022)
5 Global Sacral Neuromodulation System Market Size by Region
5.1 Global Sacral Neuromodulation System Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sacral Neuromodulation System Market Size by Region (2017-2028)
5.2.1 Global Sacral Neuromodulation System Market Size by Region: 2017-2022
5.2.2 Global Sacral Neuromodulation System Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sacral Neuromodulation System Market Size YoY Growth 2017-2028
6.1.2 North America Sacral Neuromodulation System Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sacral Neuromodulation System Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sacral Neuromodulation System Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Sacral Neuromodulation System Market Size YoY Growth 2017-2028
6.3.2 Europe Sacral Neuromodulation System Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sacral Neuromodulation System Market Size YoY Growth 2017-2028
6.4.2 Latin America Sacral Neuromodulation System Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sacral Neuromodulation System Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sacral Neuromodulation System Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Medtronic, Inc. (US)
7.1.1 Medtronic, Inc. (US) Company Details
7.1.2 Medtronic, Inc. (US) Business Overview
7.1.3 Medtronic, Inc. (US) Sacral Neuromodulation System Introduction
7.1.4 Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.1.5 Medtronic, Inc. (US) Recent Development
7.2 Boston Scientific Corporation (US)
7.2.1 Boston Scientific Corporation (US) Company Details
7.2.2 Boston Scientific Corporation (US) Business Overview
7.2.3 Boston Scientific Corporation (US) Sacral Neuromodulation System Introduction
7.2.4 Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.2.5 Boston Scientific Corporation (US) Recent Development
7.3 St. Jude Medical, Inc. (US)
7.3.1 St. Jude Medical, Inc. (US) Company Details
7.3.2 St. Jude Medical, Inc. (US) Business Overview
7.3.3 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Introduction
7.3.4 St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.3.5 St. Jude Medical, Inc. (US) Recent Development
7.4 Synapse Biomedical, Inc. (US)
7.4.1 Synapse Biomedical, Inc. (US) Company Details
7.4.2 Synapse Biomedical, Inc. (US) Business Overview
7.4.3 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Introduction
7.4.4 Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.4.5 Synapse Biomedical, Inc. (US) Recent Development
7.5 Nevro Corporation (US)
7.5.1 Nevro Corporation (US) Company Details
7.5.2 Nevro Corporation (US) Business Overview
7.5.3 Nevro Corporation (US) Sacral Neuromodulation System Introduction
7.5.4 Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.5.5 Nevro Corporation (US) Recent Development
7.6 Neurosigma, Inc. (US)
7.6.1 Neurosigma, Inc. (US) Company Details
7.6.2 Neurosigma, Inc. (US) Business Overview
7.6.3 Neurosigma, Inc. (US) Sacral Neuromodulation System Introduction
7.6.4 Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.6.5 Neurosigma, Inc. (US) Recent Development
7.7 Neuropace, Inc. (US)
7.7.1 Neuropace, Inc. (US) Company Details
7.7.2 Neuropace, Inc. (US) Business Overview
7.7.3 Neuropace, Inc. (US) Sacral Neuromodulation System Introduction
7.7.4 Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.7.5 Neuropace, Inc. (US) Recent Development
7.8 Neuronetics, Inc. (US)
7.8.1 Neuronetics, Inc. (US) Company Details
7.8.2 Neuronetics, Inc. (US) Business Overview
7.8.3 Neuronetics, Inc. (US) Sacral Neuromodulation System Introduction
7.8.4 Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.8.5 Neuronetics, Inc. (US) Recent Development
7.9 Cyberonics, Inc. (US)
7.9.1 Cyberonics, Inc. (US) Company Details
7.9.2 Cyberonics, Inc. (US) Business Overview
7.9.3 Cyberonics, Inc. (US) Sacral Neuromodulation System Introduction
7.9.4 Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.9.5 Cyberonics, Inc. (US) Recent Development
7.10 BioControl Medical (Israel)
7.10.1 BioControl Medical (Israel) Company Details
7.10.2 BioControl Medical (Israel) Business Overview
7.10.3 BioControl Medical (Israel) Sacral Neuromodulation System Introduction
7.10.4 BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2017-2022)
7.10.5 BioControl Medical (Israel) Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Sacral Neuromodulation System Market Report & Forecast 2022-2028
List of TablesTable 1. Sacral Neuromodulation System Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Sacral Neuromodulation System Market Trends
Table 3. Sacral Neuromodulation System Market Drivers
Table 4. Sacral Neuromodulation System Market Challenges
Table 5. Sacral Neuromodulation System Market Restraints
Table 6. Global Sacral Neuromodulation System Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Sacral Neuromodulation System Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Sacral Neuromodulation System Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Sacral Neuromodulation System Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Sacral Neuromodulation System Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Sacral Neuromodulation System Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Sacral Neuromodulation System Revenue Share by Player, 2017-2022
Table 13. Global Sacral Neuromodulation System Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sacral Neuromodulation System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacral Neuromodulation System as of 2021)
Table 15. Top Players of Sacral Neuromodulation System in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Sacral Neuromodulation System Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Sacral Neuromodulation System Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Sacral Neuromodulation System Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Sacral Neuromodulation System Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Sacral Neuromodulation System Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Sacral Neuromodulation System Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Sacral Neuromodulation System Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Sacral Neuromodulation System Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Sacral Neuromodulation System Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Sacral Neuromodulation System Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Sacral Neuromodulation System Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Sacral Neuromodulation System Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Medtronic, Inc. (US) Company Details
Table 31. Medtronic, Inc. (US) Business Overview
Table 32. Medtronic, Inc. (US) Sacral Neuromodulation System Product
Table 33. Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 34. Medtronic, Inc. (US) Recent Development
Table 35. Boston Scientific Corporation (US) Company Details
Table 36. Boston Scientific Corporation (US) Business Overview
Table 37. Boston Scientific Corporation (US) Sacral Neuromodulation System Product
Table 38. Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 39. Boston Scientific Corporation (US) Recent Development
Table 40. St. Jude Medical, Inc. (US) Company Details
Table 41. St. Jude Medical, Inc. (US) Business Overview
Table 42. St. Jude Medical, Inc. (US) Sacral Neuromodulation System Product
Table 43. St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 44. St. Jude Medical, Inc. (US) Recent Development
Table 45. Synapse Biomedical, Inc. (US) Company Details
Table 46. Synapse Biomedical, Inc. (US) Business Overview
Table 47. Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Product
Table 48. Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 49. Synapse Biomedical, Inc. (US) Recent Development
Table 50. Nevro Corporation (US) Company Details
Table 51. Nevro Corporation (US) Business Overview
Table 52. Nevro Corporation (US) Sacral Neuromodulation System Product
Table 53. Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 54. Nevro Corporation (US) Recent Development
Table 55. Neurosigma, Inc. (US) Company Details
Table 56. Neurosigma, Inc. (US) Business Overview
Table 57. Neurosigma, Inc. (US) Sacral Neuromodulation System Product
Table 58. Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 59. Neurosigma, Inc. (US) Recent Development
Table 60. Neuropace, Inc. (US) Company Details
Table 61. Neuropace, Inc. (US) Business Overview
Table 62. Neuropace, Inc. (US) Sacral Neuromodulation System Product
Table 63. Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 64. Neuropace, Inc. (US) Recent Development
Table 65. Neuronetics, Inc. (US) Company Details
Table 66. Neuronetics, Inc. (US) Business Overview
Table 67. Neuronetics, Inc. (US) Sacral Neuromodulation System Product
Table 68. Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 69. Neuronetics, Inc. (US) Recent Development
Table 70. Cyberonics, Inc. (US) Company Details
Table 71. Cyberonics, Inc. (US) Business Overview
Table 72. Cyberonics, Inc. (US) Sacral Neuromodulation System Product
Table 73. Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 74. Cyberonics, Inc. (US) Recent Development
Table 75. BioControl Medical (Israel) Company Details
Table 76. BioControl Medical (Israel) Business Overview
Table 77. BioControl Medical (Israel) Sacral Neuromodulation System Product
Table 78. BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2017-2022) & (US$ Million)
Table 79. BioControl Medical (Israel) Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Sacral Neuromodulation System Product Picture
Figure 2. Global Sacral Neuromodulation System Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Sacral Neuromodulation System Market Size 2017-2028 (US$ Million)
Figure 4. United States Sacral Neuromodulation System Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Sacral Neuromodulation System Market Size 2017-2028 (US$ Million)
Figure 6. United States Sacral Neuromodulation System Market Share in Global 2017-2028
Figure 7. Sacral Neuromodulation System Report Years Considered
Figure 8. Product Picture of Internal Neuromodulation System
Figure 9. Product Picture of External Neuromodulation System
Figure 10. Global Sacral Neuromodulation System Market Share by Type in 2022 & 2028
Figure 11. Global Sacral Neuromodulation System Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Sacral Neuromodulation System Market Share by Type (2017-2028)
Figure 13. United States Sacral Neuromodulation System Market Share by Type in 2022 & 2028
Figure 14. United States Sacral Neuromodulation System Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Sacral Neuromodulation System Market Share by Type (2017-2028)
Figure 16. Product Picture of Spinal Cord Stimulation
Figure 17. Product Picture of Deep Brain Stimulation
Figure 18. Product Picture of Sacral Nerve Stimulation
Figure 19. Product Picture of Vagus Nerve Stimulation
Figure 20. Global Sacral Neuromodulation System Market Share by Application in 2022 & 2028
Figure 21. Global Sacral Neuromodulation System Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Sacral Neuromodulation System Market Share by Application (2017-2028)
Figure 23. United States Sacral Neuromodulation System Market Share by Application in 2022 & 2028
Figure 24. United States Sacral Neuromodulation System Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Sacral Neuromodulation System Market Share by Application (2017-2028)
Figure 26. North America Sacral Neuromodulation System Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Sacral Neuromodulation System Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Sacral Neuromodulation System Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Sacral Neuromodulation System Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Sacral Neuromodulation System Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. UAE Sacral Neuromodulation System Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Medtronic, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 55. Boston Scientific Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 56. St. Jude Medical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 57. Synapse Biomedical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 58. Nevro Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 59. Neurosigma, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 60. Neuropace, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 61. Neuronetics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 62. Cyberonics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 63. BioControl Medical (Israel) Revenue Growth Rate in Sacral Neuromodulation System Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Keyplayers in Global and United States Sacral Neuromodulation System Market Report & Forecast 2022-2028
Medtronic, Inc. (US)Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
Request Sample
Request Discount
